Akiko Konishi
Hirakata, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Real-world efficacy of letermovir prophylaxis for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation: A single-center retrospective analysis.
Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Published: December 31, 2021
Multiple Myeloma with Central Nervous System Relapse Early after Autologous Stem Cell Transplantation: A Case Report and Literature Review.
Journal: Internal medicine (Tokyo, Japan)
Published: February 01, 2021
Analysis of HLA haplotype and clinical factors during hematopoietic stem cell transplantation.
Journal: Transplant immunology
Published: January 15, 2021
Refractory Chronic Lymphocytic Leukemia with Central Nervous System Involvement: A Case Report with Literature Review.
Journal: Journal of blood medicine
Published: October 14, 2020
Clinical efficacy of mogamulizumab for relapsed/refractory aggressive adult T-cell leukemia/lymphoma: A retrospective analysis.
Journal: European journal of haematology
Published: May 09, 2020
Six cases of autoimmune acquired coagulation factor VIII deficiency: Single center experience in Japan.
Journal: Hematology reports
Published: March 03, 2020
Comparison of starting doses of anagrelide as a first-line therapy in patients with cytoreductive therapy-naïve essential thrombocythemia: difference between starting at 0.5 and 1.0 mg/day.
Journal: International journal of hematology
Published: January 14, 2020
Trend of salvage treatment in diffuse large B cell lymphoma in the outpatient chemotherapy era.
Journal: Molecular and clinical oncology
Published: April 24, 2019
Efficacy and safety of anagrelide as a first-line drug in cytoreductive treatment-naïve essential thrombocythemia patients in a real-world setting.
Journal: European journal of haematology
Published: March 26, 2019
Neutrophil-to-lymphocyte ratio (NLR) fails to predict outcome of diffuse large B cell lymphoma.
Journal: Leukemia research reports
Published: March 23, 2019
Last Updated: 09/26/2026